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Abstract
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Science in Dentistry at Virginia Commonwealth University.
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Specific objective: Guided tissue regeneration (GTR) aims to regenerate the lost
attachment apparatus caused by periodontal disease through the use of a barrier

membrane. For the GTR procedures to be successful, barrier membranes are required to
be present at the surgical site for an extended period of time (weeks to months). Synthetic
membranes have the advantage of prolonged presence in a wound site; however, they do
not actively contribute to wound healing. Biologic membranes are recognized by the host
tissue and participate in wound healing but have the disadvantage of early resorption.
Therefore, the goal of this study is to create and characterize a hybrid barrier membrane
that contains biologically active fibrin matrix within a synthetic polymeric electrospun
scaffold.
Method: Fibrin matrices and fibrin-incorporated electrospun scaffold were created from
fresh frozen plasma at three different centrifugation conditions 400g for 12 minutes,
1450g for 15 minutes and 3000g for 60 minutes. Following centrifugation, half of the
membranes were crosslinked with 1% genipin. Biological stability of these scaffolds was
evaluated by resistance to trypsin while their mechanical properties were characterized by
MTS Bionix Uniaxial Tensile Testing System. Continuous data was analyzed by
ANOVA to detect differences between groups (p=0.05).
Results: The addition of an electrospun scaffold to the fibrin matrix led to improvements
in the mechanical properties as evidenced by an increase in the modulus (p<0.0001),
strain at break (p<0.0001) and energy to break (p<0.0001). The effect of crosslinking was
marginal but not statistically significant to the mechanical properties of fibrin matrices or
the fibrin incorporated scaffold.

However, crosslinking did significantly increase

resistance against enzymatic degradation by trypsin (p<0.0001). Lastly, centrifugation
speeds at 400g and 1450g showed similar mechanical properties and biologic stability;
meanwhile 3000g negatively impacted the properties of the scaffold.

Conclusion: Fibrin-incorporated electronspun scaffold exhibits enhanced mechanical and
biologic stability compared to fibrin matrices alone. Moreover, crosslinking improves the
biologic stability of the novel biomaterial. All these characteristics of the fibrinincorporated matrix make this membrane a potentially more ideal barrier for GTR
procedures to enhance periodontal wound healing.

Introduction
Chronic periodontitis refers to the inflammation and progressive destruction of the
supporting tissues of the periodontium resulting in loss of periodontal ligament and alveolar
bone.
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Restoration of the lost periodontium from periodontal disease is a paramount goal of

periodontal therapy. Guided tissue regeneration (GTR) aims to regenerate the lost attachment
apparatus by inducing the formation of new cementum, a new periodontal ligament and new
alveolar bone through the use of a barrier membrane.2 The principle of GTR is based on the
concept of epithelial exclusion by preventing the down-growth of epithelium to allow
mesenchymal stem cells from the PDL to repopulate the root surface and promote regeneration.3
The use of a barrier membrane in GTR also plays an important role in space maintenance
and stabilization of the clot in the initial phases of wound healing.4 Different types of barrier
membranes are available on the market ranging from synthetic to biologic membranes. The
benefits of biologic membranes, such as collagen-based membranes, include biocompatibility,
biodegradability and capability of promoting wound healing. In vivo studies have demonstrated
that collagen materials can positively influence chemotaxis of periodontal ligament fibroblasts5
and gingival fibroblasts6 to effect repair of damaged tissues. Although the biodegradable nature
of biologic membranes eliminates the need for surgical membrane retrieval, this can also be a
disadvantage when success of surgical treatment necessitates membrane presence at surgical site
for an extended period of time. Synthetic membranes, on the other hand, due to their inert nature
offer the advantage of slower resorption over biologic membranes.

However, synthetic

membranes do not actively contribute to wound healing. Furthermore, complications have also
been reported such as infection during membrane exposures that can negatively influence clinical
outcomes of regenerative procedures. 7
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There are various techniques to create synthetic membranes, and one method is through
the use of electrospinning. Electrospun scaffolds are created from polymeric solutions through
application of a high electric field between a positively charge syringe tip and a negatively
charged collector.8 The benefit of using an electrospun scaffold is the ability to adjust and control
the size of the produced fibers to create structures that closely simulate the architecture of the
natural biologic extracellular matrix. Importantly, the electrospun nanofiber structure of the
scaffolds is ideal for cell adhesion due to a greater availability of surface area for cellular
interactions. 9
The ability to add biologic activity to a synthetic membrane could have profound clinical
implications in periodontal surgical treatments. In wound healing, formation of a stable fibrin
clot is critical. Importantly, the fibrin clot serves as an excellent natural scaffold that provides a
conductive surface for cell attachment, adhesion and migration during the initial phase of
healing. 10 By incorporating a fibrin matrix into an electrospun scaffold, this novel membrane
will have the stability of a synthetic membrane to function as an excellent space maintainer, as
well as, the biological activity of the fibrin to positively influence wound healing.
Therefore, the objective of this study is to identify optimal conditions to incorporate the
fibrin matrix into the electrospun scaffold and to characterize the biologic stability and
mechanical properties of this novel biomaterial compared to fibrin matrices alone.

2

Methods

Electrospinning
Polycaprolactone (PCL) was dissolved in hexafluroisopropanol (HFP) at a concentration of
150mg/ml overnight. Once completely dissolved, polymer solution was subjected to previously
defined electrospinning conditions (rate: 7 ml/hr, air-gap distance: 12.5 cm, voltage: 22 kV) onto
a rotating mandrel revolving at 1000 rpm.
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After electrospinning, scaffold was removed from

mandrel and cut into 3”x1” uniform pieces. Scaffolds were treated with acid conditioning using
38% hydrochloric acid and washed with PBS for 5 minutes.

Preparation of fibrin-incorporated electron scaffold
Firbin matrices and fibrin-incorporated electrospun scaffolds were created at three different
centrifugation conditions: 400g for 12 minutes, 1450g for 15 minutes and 3000g for 60 minutes.
Twelve replicates were created for each of the centrifugation conditions. Each sample was
prepared using 4mL of fresh frozen human plasma at 37oC mixed with 100µL of 1M CaCl2 into
scaffold containing test tubes under sterile conditions. After centrifugation, the cylindricalshaped fibrin clots and fibrin-incorporated electrospun scaffolds were gently removed and
compressed to make membranes (Figure 1).

Genipin crosslinking of fibrin-incorporated electrospun scaffolds
Under sterile conditions, half of the compressed membranes created at 400g, 1450g and 3000g
were placed in six well culture plates and submerged in 4mL of 1% genipin for 48 hours. After
48 hours, membranes were washed twice with PBS. All uncrosslinked (UN-XL) and crosslinked
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(XL) membranes were stored at 4oC in PBS solution until mechanical proprieties of the samples
were analyzed.

Biodegradation assay with trypsin
The effect of crosslinking on the fibrin clot and fibrin-incorporated electrospun scaffold was
assayed by trypsin degradation. Six samples of the fibrin clot alone and six samples of the fibrinincorporated electrospun scaffolds were created from each of the centrifugation conditions at
400g, 1450g and 3000g. Half of the samples were later cross-linked with 1% genipin for
48hours, as previously described. Following crosslinking, samples were placed in six well
culture plates, mixed with 500L of 0.01% trypsin and incubated at 37oC for 48 hours (Figure 2).
All samples were individually weigh prior to degradation assay, and measured again at the
completion of 48 hours (Figure 3).

Uniaxial tensile testing
The mechanical properties of the electrospun scaffold alone (S), uncrosslinked fibrin clots (UNXL-F, crosslinked fibrin clots (XL-F), uncrosslinked fibrin-incoporated electrospun scaffold
(UN-XL-S) and crosslinked fibrin-incorporated scaffolds (XL-S) were analyzed by uniaxial
tensile testing. Preparation for uniaxial testing involved determining the thickness of each
scaffold and cutting it into “dog bone” specimens measuring 2.75mm wide at their narrowest
point with a length of 7.5mm (Figure 4). Each specimen was then mounted onto the MTS
Bionix 200 testing system (MTS Systems Corp) and stretched at rate of 10.0mm/min (Figure 5).
Elastic modulus, energy to break and strain at break were calculated by MTS software
TestWorks 4.0 and recorded.
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Statistical Analyses
Multi-way ANOVA models were used to assess the relationship between various measures
(degradation, modulus, strain at break, energy to break) based on the presence or absence of the
scaffold, crosslinking, and centrifuge speed. A three-way interaction was fit to allow for
differences based on the combination. Post-hoc pairwise comparisons were performed to
determine where there were differences in materials combinations. A conservative Tukey’s HSD
adjustment was used to account for multiple comparisons. A significance level of 0.05 and SAS
EG v6.1 was used for all analyses.
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Result

ANOVA model results are presented in Table 1 for each of the measures of interest. This table
shows what factors were associated with differences in stability, modulus, strain at break, and
energy to break. Specifically, presence of a scaffold is statistically significant for all outcomes,
but was influenced by other factors (centrifuge rate and/or crosslinking) on trypsin degradation,
modulus, and strain at break. Crosslinking was significant for all outcomes except modulus (pvalue=0.0969). Centrifuge rates were significantly associated with differences in trypsin
degradation and modulus.

Baseline scaffold mechanical properties
Results from the uniaxial tensile strength test of the electrospun scaffold alone reported a mean
modulus value of 47MPa. The strain at break was 4.1 and the energy to break was 100.7N*mm
(Table 2).
Trypsin Degradation
Results from ANOVA model of the percent of the sample remaining after 48 hour degradation
with trypsin demonstrated a significant 3-way interaction for the presence of a scaffold, crosslinking, and the centrifuge rate (p-vlaue= 0.0064). The highest percent remaining was seen with
crosslinked samples with scaffold when spun at 1450g, though this combination was not
significantly different from that at 400g, or the samples with no scaffold when spun at 400g or
1450g and crosslinked. The general trend is that increased centrifuge rates decrease the
degradation, cross-linking greatly increases the percent remaining, and the addition of the
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scaffold provides marginal, but not significant increased stability. Estimated percent remaining is
presented in Figure 6. All pairwise comparisons of interest are presented in Table 3.

Modulus
There was a significant interaction between the presence of the scaffold and the centrifuge rate
when modeling modulus (p-value=0.0007). Specifically, there were no significant differences in
modulus based on centrifuge rate for fibrin matrix alone, but with fibrin+scaffold, as the
centrifuge rate increased the modulus decreased. There was a statistically significantly higher
modulus for samples with scaffold when spun at 400g vs 3000g (p-value<0.0001) (Table 4).
Overall, modulus was greatly increased with the presence of the scaffold (average 52.9 vs
1.1MPa). The effect of crosslinking was marginal but not statistically significant (0.0969). Figure
7 presents the estimated modulus for each sample combination. Pairwise comparisons by
scaffold and centrifuge rate are presented in Table 4.

Strain at Break
The effect of crosslinking on strain at break was different based on the presence of a scaffold (pvalue<0.0001) (Table 1). Centrifuge speed was not significantly associated with a change in
strain at break (p-value=0.2116). The effect of crosslinking was negligible for samples with no
scaffold (p-value-0.9116), but significant in presence of scaffold. For samples with scaffold,
crosslinking significantly decreased the strain at break by an average of 1.44mm/mm (pvalue<0.0001). The greatest strain at break was seen in un-crosslinked samples with a scaffold,
spun at 1450g, but this was not significantly different from samples at either of the other two
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centrifuge rates (400 or 3000g). Figure 8 presents the estimated mean strain at break and Table 5
presents the pairwise comparisons for the interaction of scaffold and crosslinking.

Energy to Break
The only statistically significant predictor of energy to break was the presence or absence of a
scaffold (p-value<0.0001) (Table 1). The presence of a scaffold increased the energy to break by
over 90N*mm (Table 5). After adjusting for scaffold, the effects for the crosslinking and
centrifuge rate were not significantly different. Estimated mean energy to break is presented in
Figure 9.
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Discussion

In this study, the initial objective was to identify the optimal centrifugation conditions to
create a biologically active membrane by incorporating fibrin matrix into an electrospun
scaffold. It is known, based on the principle of centrifugation, that altering the centrifugation
force will influence the rate of sedimentation.12 Specifically, that increasing the centrifugation
force leads to greater compaction and formation of a denser construct. Applying this concept,
three varying centrifugation speeds (400g, 1450g and 3000g) were selected to evaluate effects on
the mechanical properties of the novel membrane. 400g was selected as the benchmark since this
is the centrifugation protocol currently used for the creation of L-PRF through the Intra-Spin
system (Intra-Lock)13. 3000g was selected as the upper limit of the centrifugation speed as this
was the greatest speed permitted on the centrifuge. Lastly, 1450g was selected as the relative
halfway mark between 400g and 3000g. It was hypothesized that the membranes created at
3000g would exhibit enhanced mechanical properties due to greater condensation of the fibrin
matrix at an increased centrifugation force.
Based on the results from the uniaxial mechanical test, the mechanical properties of the
fibrin-incorporated electrospun scaffold exhibited similar characteristics at 400g and 1450g with
no statistical significant difference in the modulus, energy to break or strain at break. Meanwhile,
the novel membrane created at 3000g exhibited a statistically significant decrease in the
modulus, irrespective if the membrane was crosslinked, compared to membranes created at 400g
or 1450g (Figure 7). However, centrifugation speed at 3000g did not show any statistical
significant difference in the strain at break or energy to break compared to 400g or 1450g.
The modulus describes the elastic properties of a material and measures the resistance of
the material to elastic deformation under load14. In other words, the modulus refers to the
9

stiffness of the material. Our study reported that an increase in the centrifugation speed altered
the stiffness of the membrane. In clinical practice, a membrane with a higher modulus would be
preferred since this would imply that the material can withstand greater stress and minimally
changes its shape under elastic load. It is possible that a significant increase in the centrifugation
force did not allow the fibrin matrix to properly engage with the nanostructure of the electrospun
scaffold during the polymerization process. Rather, the fibrin matrix was simply layered on top
of the scaffold and thus membranes created at 3000g lacked the inherent stiffness of the scaffold
and could explain the observed decrease in modulus.
The ability to affect the stability of the novel biomaterial was also examined through the
effects of crosslinking. Crosslinking is the process of chemically joining two or more molecules
together with the purpose of stabilizing the protein structure15. Fibrin is generally present up to 1
week in the body before it is remodeled during wound healing16. It was hypothesized that
crosslinking can increase the stability of the fibrin matrix and increase resistance against
enzymatic degradation to trypsin. Trypsin is a serine protease found in the human body and
functions to hydrolyze protein17. The trypsin degradation assay is an indirect method to evaluate
the stability of the fibrin matrix after crosslinking and to assess if the addition of an electrospun
scaffold would alter the stability of the fibrin clot.
Our study showed a general trend that crosslinking significantly increased the stability of
both the fibrin clots and fibrin-incorporated electrospun scaffolds (Figure 6).

This was

evidenced by a statistically greater percentage of remaining constructs after the 48-hour
incubation period with trypsin. Moreover, in the absence of crosslinking, the addition of scaffold
was beneficial and decreased the degradation of the fibrin matrix. However, in the presence of
crosslinking, the addition of the scaffold provided marginal but not significant increase in
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stability. The one exception was seen in the 3000g group where the addition of scaffold to
crosslinking significantly decreased the rate of degradation. It is likely that the increase in
centrifugation speed altered the fibrin polymerization process and negatively impacted the
structural architecture of the fibrin matrix, especially in the absence of a scaffold. However, with
the addition of the scaffold to the fibrin matrix at 3000g, it was able to compensate for changes
in the structural integrity of the fibrin clot and improve the overall stability.
The effect of crosslinking was also observed in the mechanical properties of the novel
biomaterial, specifically decreasing the strain at break. In fact, in the presence of crosslinking
and scaffold, the strain at break is reduced to the same levels of the fibrin matrix alone
irrespective of crosslinking. The strain at break of a material refers to the maximum stress a
material can stand before it breaks as stress is applied to the material18. A decrease in the strain at
break translates into a material that exhibits a decrease in the ability to be stretched. One possible
explanation is that crosslinking can result in significant dehydration making the material more
stiff and reduces ability to be stretched. However, when the membrane is uncrosslinked, the
presence of scaffold significantly increased the strain at break allowing the membrane to be
stretched.
In conclusion, our results showed that the combined presence of both the fibrin matrix
and electrospun led to statistically significant improvements in mechanical properties.
Meanwhile, crosslinking enhanced the biologic stability of the fibrin matrix as evidenced by a
greater resistance against enzymatic degradation following the trypsin degradation assay. Lastly,
centrifugation speeds at 400g and 1450g produced membranes exhibiting similar mechanical
properties. However, at 3000g the mechanical properties were negatively influenced by an
increase in the centrifugation speed. Based on the results of this study, our recommendation for a
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novel membrane that exhibits enhanced biologic stability and superior mechanical properties are
crosslinked fibrin-incorporated scaffold generated at 400g. In summary, creation of a hybrid
barrier membrane that contains biologically active fibrin matrix into a synthetic polymeric
electrospun scaffold has great potential as a novel biomaterial in periodontal surgery.
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Figure 1: Preparation of fibrin-incorporated electrospun scaffold -A) Cylindrical-shaped fibrinincorporated electrospun scaffolds were created at 400g, 1450g, and 3000g, B) gently
compressed to form membranes

(A)
400g

1450g

3000g

(B)
Figure 2: Biodegradation assay with trypsin - biological stability of the fibrin matrices and fibrinincorporated scaffolds was evaluated with resistance against enzymatic degradation to trypsin
(A- uncrosslinked, B- crosslinked samples)
(A)

400g

1450g

3000g

(B)

400g

1450g

3000g
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Figure 3: Biodegradation assay with trypsin - completion of biodegradation assay following 48hour incubation period with trypsin at 37 C degrees (A- uncrosslinked, B- crosslinked samples)
(A)

(B)

400g

400g

1450g

3000g

1450g

3000g

Figure 4: Preparation of specimens for uniaxial tensile testing - Preparation of samples into “dog
bone” specimens measuring 2.75mm wide at their narrowest point with a length of 7.5mm
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Figure 5: Uniaxial tensile testing - Illustration of mounted specimen on the MTS Bionix Uniaxial
Tensile Testing System to characterize the mechanical properties of the fibrin-incorporated
electrospun scaffold
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Figure 6: Mean Percent Remaining after Trypsin Degradation

Figure 7: Estimated Mean Modulus (MPa)
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Figure 8: Estimated Strain at Break

Figure 9: Estimated Energy to Break (N*mm)
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Table 1: ANOVA Model Results
Trypsin
Degradation
<.0001*
<.0001*
<.0001*
<.0001*
<.0001*
0.2290

Scaffold (Yes/No)
Centrifuge Rate (400, 1450, 3000)
Crosslinking (XL or UNXL)
Scaffold*Centrifuge Rate
Centrifuge Rate * Crosslinking
Scaffold*Crosslinking
Scaffold*Centrifuge
Rate*Crosslinking
0.0064*
*Statistically significant at 0.05 level

Modulus
<.0001*
0.0008*
0.0969
0.0007*
0.8140
0.1307

Strain at Energy
Break
Break
<.0001*
<.0001*
0.2116
0.5871
<.0001*
0.0736
0.2777
0.5974
0.9735
0.2512
<.0001*
0.0544

0.8352

0.4000

0.2831

Table 2: Baseline Scaffold Mechanical Properties
Modulus (MPa)
Strain at Break (mm/mm)
Energy to Break (N*mm)

Mean
47.0
4.1
100.7
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Standard Deviation
1.44
0.37
6.72

to

Table 3: Pairwise Comparisons of Percent Remaining for Scaffold, Crosslinking, Centrifuge
Rates
Estimated
Difference
(% Remaining)
-60%
-89%
-30%
-83%
-77%
-33%
36%
36%
0%
6%
66%
59%
-7%
-32%
-25%
-1%
18%
19%
20%
-22%
-47%
-3%
-11%
-51%

Comparison
No Scaffold at 400g: UNXL vs XL
No Scaffold at 1450g: UNXL vs XL
No Scaffold at 3000g: UNXL vs XL
Scaffold at 400g: UNXL vs XL
Scaffold at 1450g: UNXL vs XL
Scaffold at 3000g: UNXL vs XL
No Scaffold UNXL: 400g vs 1450g
No Scaffold UNXL: 400g vs 3000g
No Scaffold UNXL: 1450g vs 3000g
No Scaffold XL: 400g vs 1450g
No Scaffold XL: 400g vs 3000g
No Scaffold XL: 1450g vs 3000g
Scaffold UNXL: 400g vs 1450g
Scaffold UNXL: 400g vs 3000g
Scaffold UNXL: 1450g vs 300g
Scaffold XL: 400g vs 1450g
Scaffold XL: 400g vs 3000g
Scaffold XL: 1450g vs 3000g
UNXL at 400g: No Scaffold vs Scaffold
UNXL at 1450g: No Scaffold vs Scaffold
UNXL at 3000g: No Scaffold vs Scaffold
XL at 400g: No Scaffold vs Scaffold
XL at 1450g: No Scaffold vs Scaffold
XL at 3000g: No Scaffold vs Scaffold

Adj P
<.0001*
<.0001*
<.0001*
<.0001*
<.0001*
<.0001*
<.0001*
<.0001*
1
0.9887
<.0001*
<.0001*
0.9637
<.0001*
0.0001*
1
0.0235*
0.0096*
0.0044*
0.001*
<.0001*
1
0.6658
<.0001*

Table 4: Comparison of Mean Modulus by Scaffold and Centrifuge Rates
Comparison
400g: No Scaffold vs Scaffold
1450g: No Scaffold vs Scaffold
3000g: No Scaffold vs Scaffold
No Scaffold: 1450g vs 3000g
No Scaffold: 400g vs 1450g
No Scaffold: 400g vs 3000g
Scaffold: 1450g vs 3000g
Scaffold: 400g vs 1450g
Scaffold: 400g vs 3000g

Estimated Difference (MPa)
-65.70
-52.21
-37.60
-0.20
-0.01
-0.21
14.41
13.47
27.88
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Adj P
<.0001
<.0001
<.0001
1
1
1
0.0403
0.0600
<.0001

Table 5: Comparison of Mean Strain at Break by Scaffold and Crosslinking
Comparison
UNXL: No Scaffold vs Scaffold
No Scaffold: UNXL vs XL
Scaffold: UNXL vs XL
XL: No Scaffold vs Scaffold

Estimated Difference (mm/mm)
-1.09
0.09
1.44
0.26

Adj P
<.0001*
0.9116
<.0001*
0.2193

Table 6: Estimated Mean Energy to Break for Scaffold (Yes/No)
Estimated Mean
Scaffold
(N*mm)
No Scaffold
2.0
Scaffold
95.5
Difference (No Scaffold-Scaffold)
-93.5
*P-value for t-test of difference in means
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SE
3.55
3.45
4.95

P-value*
<0.0001

